FDA panel reviewing some peptides to consider loosening regulations for unapproved therapies
A Food and Drug Administration advisory panel will spend the next two days discussing whether compounding pharmacies can fill prescriptions for some unapproved peptides. The meeting comes amid a surge of interest in the unapproved therapies. Peptides are short strings of amino acids, the building blocks of proteins, linked by chemical bonds. The human body … Read more
